A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/00 (2006.01) A01N 43/40 (2006.01) A61K 9/20 (2006.01) C07D 213/74 (2006.01)
Patent
CA 2455881
Novel, stable pharmaceutical formulations for the oral administration of high purity torsemide modification II are disclosed. These formulations release high purity torsemide modification II in water at a constant and high purity rate, and the high purity torsemide modification II therein does not rearrange to torsemide modification I over time. Methods for their manufacture are also disclosed.
L'invention concerne des nouvelles formulations pharmaceutiques stables destinées à une administration orale de torsemide de modification II de grande pureté. Ces formulations libèrent du torsemide de modification II de grande pureté dans de l'eau à un taux de pureté constant et élevé, et ledit torsemide de modification II de grande pureté ne se réagence pas en torsemide de modification I avec le temps. L'invention concerne également des procédés de production associés.
Aronhime Judith
Kopel Mira
Kordova Marko
Leibovici Minutza
Tenengauzer Ruth
Blake Cassels & Graydon Llp
Teva Pharmaceutical Industries Ltd.
LandOfFree
A stable pharmaceutical formulation comprising torsemide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A stable pharmaceutical formulation comprising torsemide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A stable pharmaceutical formulation comprising torsemide... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1855321